Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients

Cytometry Part A

Volumn 69, Issue 5, 2006, Pages 359-373

  Prunet, Céline ^a   Montange, Thomas ^a   Véjux, Anne ^a   Laubriet, Aline ^a   Rohmer, Jean François ^b   Riedinger, Jean Marc ^c   Athias, Anne ^a   Lemaire Ewing, Stéphanie ^a   Néel, Dominique ^a   Petit, Jean Michel ^a   Steinmetz, Eric ^a   Brenot, Roger ^a   Gambert, Philippe ^a   Lizard, Gérard ^a  

^a HÔPITAL DU BOCAGE   (France)

^b Centre d'Examens de Santé de la Caisse Primaire d'Assurance Maladie de Côte d'Or   (France)

^c Centre Anti Cancer GF Leclerc   (France)

Author keywords

Atherosclerosis; CRP; Cytokines; Flow cytometric bead based assays; Oxysterols

Indexed keywords

25 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYSTEROL; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; MICROSPHERE; STEROL;

ADULT; AGED; ANALYTIC METHOD; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FRANCE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MONOCYTE; MULTIPLEXED FLOW CYTOMETRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; ARTERIOSCLEROSIS; BIOLOGICAL MODEL; BLOOD; CELL DEATH; CELL STRAIN U937; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PHOSPHORYLATION; TH1 CELL;

AGED; ARTERIOSCLEROSIS; CELL DEATH; CULTURE MEDIA; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MALE; MICROSPHERES; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; MONOCYTES; PHOSPHORYLATION; STEROLS; TH1 CELLS; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 33745788418     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20272     Document Type: Article

References (72)

1. Strong JP. Atherosclerotic lesions. Natural history, risk factors, and topography. Arch Pathol Lab Med 1992;116:1268-1275.
2. Lusis AJ. Atherosclerosis. Nature 2000;407:233-241.
3. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983;52:223-261.
4. Kellner-Weibel G, Jerome WG, Small DM, Warner GJ, Stoltenborg JK, Kearney MA, Corjay MH, Phillips MC, Rothblat GH. Effects of intracellular free cholesterol accumulation on macrophage viability. A model for foam cell death. Arterioscler Thromb Vasc Biol 1998;18:423-431.
5. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002;8:1235-1242.
6. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
7. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol 1992;42:277-290.
8. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
9. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the center for disease control and prevention and the American Heart Association. Circulation 2003;107:499-511.
10. Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipidol 1998;9:397-405.
11. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombol 2004;17:35-44.
12. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman J, Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 in cholesterol-loaded human macrophages. Relevance to stability of atherosclerotic plaque. Circulation 1999;99:420-426.
13. Michel JB. Constating outcomes of atheroma evolution: Intimal accumulation versus medial destruction. Arterioscler Thromb Vasc Biol 2001;21:1389-1392.
14. Libby P. Inflammation and atherosclerosis. Nature 2002;420:868-874.
15. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1-28.
16. Ziedèn B, Kaminskas A, Kristenson M, Kucinskiene Z, Vessby B, Olsson AG, Diczfalusy U. Increased plasma 7β-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arterioscler Thromb Vasc Biol 1999;19:967-971.
17. Vaya J, Aviram M, Mahmood S, Hayek T, Grenadir E, Hoffman A, Milo S. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 2001;34:485-497.
18. Lemaire S, Lizard G, Monier S, Miguet C, Gueldry S, Volot F, Gambert P, Néel D. Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α-, 7β-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett 1998;440:434-439.
19. Liu Y, Hulten LM, Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol 1997;17:317-323.
20. Lizard G, Lemaire S, Monier S, Gueldry S, Néel D, Gambert P. Induction of apoptosis and of interleukin-1β secretion by 7β-hydroxycholesterol and 7-ketocholesterol: Partial inhibition by Bcl-2 overexpression. FEBS Lett 1997;419:276-280.
21. Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Tedgui A. Expression of interleukine-10 in advanced atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999;19:611-616.
22. Sherer Y, Shoenfeld Y. Immunomodulation for treatment and prevention of atherosclerosis. Autoimmun Rev 2002;1:21-27.
23. Sano H, Nakagawa N, Chiba R, Kurasawa K, Saito Y, Iwamoto I. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem Biophys Res Commun 1998;250:694-698.
24. O'Brien D, O'Connor T, Shanakan F, O'Connell J. Activation of the p38 MAPK and ERK1/2 pathways is required for Fas-induced IL-8 production. Ann N Y Acad Sci 2002;973:161-165.
25. Bian ZB, Elner SG, Yoshida A, Elner VM. Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade. Exp Eye Res 2003;76:573-583.
26. Lizard G, Moisant M, Cordelet C, Monier S, Gambert P, Lagrost L. Induction of similar features of apoptosis in human and bovine vascular endothelial cells treated by 7-ketocholesterol. J Pathol 1997;183:330-338.
27. Pedruzzi E, Guichard C, Ollivier V, Driss F, Fay M, Prunet C, Marie JC, Pouzet C, Samadi M, Elbim C, O'Dowd Y, Bens M, Vandewalle A, Gougerot-Pocidalo MA, Lizard G, Ogier-Denis E. NAD(P)H-oxidase Nox-4 mediates 7-ketocholesterol- induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 2004;24:10703-10717.
28. Clare K, Hardwick SJ, Carpenter KLH, Weeraunge N, Mitchinson MJ. Toxicity of oxysterols to human monocyte-macrophage. Atherosclerosis 1995;118:67-75.
29. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophages foam cells in human atheroma. J Biol Chem 1996;271:8837-8842.
30. O'Callaghan YC, Woods JA, O'Brien NM. Comparative study of the cytotoxicity and apoptosis-inducing potential of commonly occuring oxysterols. Cell Biol Toxicol 2001;17:127-137.
31. Berthier A, Lemaire-Ewing S, Prunet C, Athias A, Bessède G, Pais de Barros JP, Laubriet A, Gambert P, Lizard G, Néel D. Involvement of a calcium-dependent dephosphorylation of BAD associated with localization of Trpc-1 within rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 2004;11:897-905.
32. Mazer SP, Rabbani LE. Evidence for C-reactive protein's role in (CRP) vascular disease: Atherothrombosis, immunoregulation and CRP. J Thromb Thrombol 2004;17:95-105.
33. Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-1890.
34. Kaul D. Molecular link between cholesterol, cytokines and atherosclerosis. Mol Cell Biochem 2001;219:65-71.
35. Boisvert WA. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 2004;14:161-165.
36. Emmerich J. Epidemiology of venous thrombosis. Bull Acad Natl Med 2003;187:19-32.
37. Lizard G, Gueldry S, Sordet O, Monier S, Athias A, Miguet C, Bessede G, Lemaire S, Solary E, Gambert P. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J 1998;12:1651-1663.
38. Vignali DAA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243-255.
39. Kellar KL, Iannone MA. Multiplexed microsphere-based flow cytometric assays. Exp Hematol 2002;30:1227-1237.
40. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP. Simultaneous measurement of six cytokines in a single sample of human tears using microparticule-based flow cytometry: Allergics vs. non-allergics. J Immunol Methods 2001;254:109-118.
41. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1983;150:76-85.
42. Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Berthier A, Bessède G, Corcos L, Gambert P, Néel D, Lizard G. Comparison of the cytotoxic, prooxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005;21:97-114.
43. Yeh CG, Hsi B, Faulk WP. Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J Immunol Methods 1981;43:269-275.
44. Miguet C, Monier S, Bettaieb A, Athias A, Bessède G, Laubriet A, Lemaire S, Néel D, Gambert P, Lizard G. Ceramide generation occuring during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ 2001;8:83-99.
45. Lizard G, Fournel S, Genestier L, Dhedin N, Chaput C, Flacher M, Mutin M, Panaye M, Revillard JP. Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry 1995;21:275-283.
46. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
47. Björkhem I, Reihner E, Angelin B, Ewerth S, Akerlund JE, Einarsson K. On the possible use of the serum level of 7α-hydroxycholesterol as a marker for increased activity of the cholesterol 7α-hydroxylase in humans. J Lipid Res 1987;28:889-894.
48. Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995;225:73-80.
49. Salonen JT, Nyyssonen K, Salonen R, Porkkala-Sarataho E, Tuomainen TP, Diczfalusy U, Björkhem I. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997;95:840-845.
50. Mol MJTM, de Rijke YB, Demacker PNM, Stalenhoef AFH. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: Effects of vitamin E treatment. Atherosclerosis 1997;129:169-176.
51. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
52. Martinet W, Kockx MM. Apoptosis in atherosclerosis: Focus on oxidized lipids and inflammation. Curr Opin Lipidol 2001;12:535-541.
53. Aikawa M, Libby P. Atherosclerotic plaque inflammation: The final frontier? Can J Cardiol 2004;20:631-634.
54. Ohsuzu F. The roles of cytokines, inflammation and immunity in vascular diseases. J Atheroscler Thromb 2004;11:313-321.
55. Zernecke A, Weber C. Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 2005;100:1-9.
56. Danesh J, Wheeler JG, Hirschneid G, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys M, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397.
57. Zhou Q, Wasowicz E, Handler B, Fleischer L, Kummerow FA. An excess concentration of oxysterols in the plasma is cytotoxic to cultured endothelial cells. Atherosclerosis 2000;149:191-197.
58. Iuliano L, Micheletta F, Natoli S, Corradini G, Iapelli M, Elisei W, Giovanelli L, Violi F, Diczfalusy U. Measurement of oxysterols and α-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem 2003;312:217-223.
59. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev 2002;1:233-237.
60. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 2003;14:421-430.
61. Lamb DJ, El-Sankary W, Ferns GAA. Molecular mimicry in atherosclerosis: A role for heat shock proteins in immunisation. Atherosclerosis 2002;167:177-185.
62. Xu Q. Infections, heat shock proteins, and atherosclerosis. Curr Opin Cardiol 2003;18:245-252.
63. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verbeugt FWA, Wolbink GJ, Hack CE. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 1999;100:96-102.
64. Leonarduzzi G, Gamba P, Sottero B, Kadl A, Robbesyn F, Calogero RA, Biasi F, Chiarpotto E, Leitinger N, Sevanian A, Poli G. Oxysterol-induced up regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic Biol Med 2005;39:1152-1161.
65. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ. Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb 1994;1 (Suppl 1):S10-S13.
66. Sheikine Y, Hansson GK. Chemokines and atherosclerosis. Ann Med 2004;36:98-118.
67. Schecter AD, Rollins BJ, Zhang YJ, Charo IF, Fallon JT, Rossikhina M, Giesen PL, Nemerson Y, Taubman MB. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem 1997;272:28568-28573.
68. 2+ oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis 2000;153:23-35.
69. Na YJ, Jeon YJ, Suh JH, Kang JS, Yang KH, Kim HM. Suppression of IL-8 gene expression by radicicol is mediated through the inhibition of ERK1/2 and p38 signaling and negative regulation of NF-κB and AP-1. Int Immunopharmacol 2001;1:1877-1887.
70. Li Y, Schwabe RF, DeVries-Seimon T, Yao PM, Gerbod-Giannone MC, Tall AR, Davis RJ, Flavell R, Brenner DA, Tabas I. Free cholesterol-loaded macrophages are an abundant source of TNF-α and IL-6: Model of NF-κB and MAPK-dependent inflammation in advanced atherosclerosis. J Biol Chem 2005;280:21763-21775.
71. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565.
72. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP. Multiplex bead assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 2004;61:35-39.